AlzChem Group Aktie
WKN DE: A2YNT3 / ISIN: DE000A2YNT30
21.04.2022 16:17:48
|
DGAP-News: Alzchem Group AG receives award from EcoVadis for its sustainability successes
DGAP-News: AlzChem Group AG
/ Key word(s): Sustainability
Alzchem Group AG receives award from EcoVadis for its sustainability successes Dr. Georg Weichselbaumer, CSO of Alzchem Group AG: "We are proud to have been awarded the Gold Medal again by EcoVadis. It is particularly pleasing that we were able to further improve by 2 points compared to 2020 despite tighter requirements. This result underlines our ambition to improve continuously - not only in economic terms, but also from an ESG perspective. Only the highest standards in sustainability, in socially as well as ethically correct behavior remain our benchmark in order to give our customers and partners the assurance that we are a responsible and trustworthy partner also in these matters." About Alzchem The company sees interesting growth prospects for itself especially in the areas of human and animal nutrition and agriculture. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and our creatine products can contribute to healthy aging as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective. The broad product range of Alzchem Group AG includes dietary supplements, precursors for corona tests and pharmaceutical raw materials. These products are our company's response to global trends and developments. Alzchem is ideally positioned in this regard and sees itself as well equipped for an environmentally oriented future and global developments. The company employs around 1,630 people at four production sites in Germany and one plant in Sweden, as well as two sales companies in the USA and China. In 2021, Alzchem generated consolidated sales of around EUR 422.3 million and EBITDA of around EUR 62.0 million.
21.04.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | Alzchem Group AG |
Dr.-Albert-Frank-Str. 32 | |
83308 Trostberg | |
Germany | |
Phone: | +498621862888 |
Fax: | +49862186502888 |
E-mail: | ir@alzchem.com |
Internet: | www.alzchem.com |
ISIN: | DE000A2YNT30 |
WKN: | A2YNT3 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart |
EQS News ID: | 1332379 |
End of News | DGAP News Service |
|
1332379 21.04.2022

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu AlzChem Group AG Inhaber-Akt Nach Kapitalherabsetzungmehr Nachrichten
27.03.25 |
EQS-HV: Alzchem Group AG: Bekanntmachung der Einberufung zur Hauptversammlung am 08.05.2025 in Trostberg mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG (EQS Group) | |
26.03.25 |
SDAX aktuell: SDAX sackt zum Ende des Mittwochshandels ab (finanzen.at) | |
26.03.25 |
Starker Wochentag in Frankfurt: SDAX verbucht Zuschläge (finanzen.at) | |
25.03.25 |
Aufschläge in Frankfurt: SDAX zum Ende des Dienstagshandels in der Gewinnzone (finanzen.at) | |
25.03.25 |
Pluszeichen in Frankfurt: SDAX am Dienstagnachmittag mit Zuschlägen (finanzen.at) | |
25.03.25 |
Dienstagshandel in Frankfurt: SDAX mittags in Grün (finanzen.at) | |
25.03.25 |
Gewinne in Frankfurt: SDAX bewegt sich zum Handelsstart im Plus (finanzen.at) | |
24.03.25 |
Handel in Frankfurt: SDAX beendet die Sitzung weit in der Verlustzone (finanzen.at) |
Analysen zu AlzChem Group AG Inhaber-Akt Nach Kapitalherabsetzungmehr Analysen
18.03.25 | AlzChem Group Buy | Warburg Research | |
11.03.25 | AlzChem Group Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
07.03.25 | AlzChem Group Add | Baader Bank | |
28.02.25 | AlzChem Group Buy | Warburg Research | |
28.02.25 | AlzChem Group Add | Baader Bank |